Filing Flows › Alnylam Pharmaceuticals (ALNY) › Recalls, complaints & regulation
Alnylam Pharmaceuticals (ALNY): clinical trials
Alnylam Pharmaceuticals (ALNY) beyond its filings: 26 active clinical trials.
Alnylam Pharmaceuticals' latest quarter
Alnylam Pharmaceuticals, Q3 2026: revenue $1.5B (+17% year over year), operating margin 23.7%, net earnings $2.2B, operating cash flow $341M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Alnylam Pharmaceuticals have?
26 active studies on ClinicalTrials.gov, 5 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.